A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab
- 29 October 2010
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 62 (11) , 3191-3195
Abstract
We describe a 72‐year‐old white man with erosive rheumatoid arthritis in whom subacute neurologic and psychiatric symptoms developed after 3 years of treatment with infliximab, prednisone, and methotrexate. White matter demyelination was seen on magnetic resonance imaging of the brain, and progressive multifocal leukoencephalopathy (PML) was ultimately confirmed by brain biopsy. The patient was treated with supportive therapy and discontinuation of disease‐modifying antirheumatic drugs, resulting in stabilization of the disease process. The patient survived, but neurologic and cognitive deficits persisted. The distribution and pathology of this patient's disease are unique from almost all reported incidents of oral methotrexate–associated leukoencephalopathy. The pathogenesis of disease may be linked to a T cell–mediated process that is potentially impacted by infliximab. This case provides the first reported evidence that PML can be seen in association with infliximab therapy.Keywords
This publication has 16 references indexed in Scilit:
- Determinants of survival in progressive multifocal leukoencephalopathyNeurology, 2009
- Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritisArthritis & Rheumatism, 2009
- Progressive multifocal leucoencephalopathy associated with lupus and methotrexate overdoseLupus, 2008
- Disseminated necrotizing leukoencephalopathy following low‐dose oral methotrexateEuropean Journal of Neurology, 2007
- Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patientsJournal of Neuroimmunology, 2006
- Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy IndividualsJournal of Virology, 2004
- A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathyBrain, 2004
- Reversible posterior leucoencephalopathy during oral treatment with methotrexateJournal of Neurology, 2004
- Low Frequency of Cytotoxic T Lymphocytes against the Novel HLA-A*0201-Restricted JC Virus Epitope VP1p36in Patients with Proven or Possible Progressive Multifocal LeukoencephalopathyJournal of Virology, 2003
- Therapy with infliximab decreases the CD4+CD28? T cell compartment in peripheral blood in patients with rheumatoid arthritisRheumatology International, 2003